重新审视常规:美国麻醉医师协会1级和2级患者低风险门诊手术前的术前实验室检查——2017年美国国家手术质量改进计划队列分析
本研究回顾性分析2017年NSQIP数据库中111,589例ASA 1-2级接受低风险择期门诊手术的患者,发现51.6%接受了术前实验室检查,其中46.4%至少一项异常。
要点
- 超过半数ASA 1-2级低风险门诊手术患者仍接受术前实验室检查,与指南推荐不符
- 检查组并发症率仅略高于未检查组(2.5% vs 1.7%),死亡率无差异
- 避免一例严重并发症需检查599例,避免任何并发症需133例,提示检查效率低
核心结论
- 尽管指南不推荐,多数ASA 1-2级低风险门诊手术患者仍接受术前实验室检查。
- 检查组与未检查组并发症率差异小,死亡率无差异,检查应更审慎以节约成本。
研究设计与样本
- 回顾性查询2017年NSQIP数据库,纳入ASA 1级和2级接受低风险择期门诊手术的患者共111,589例。
- 术前实验室检查定义为术前30天内进行的任何化学、血液学、凝血或肝功能检查。
- 比较检查与未检查组的人口学、合并症和结局,计算需检查人数(NNT)以预防严重并发症或任何并发症,并基于CMS数据估算检查成本。
主要发现
- 57,590例(51.6%)接受了术前实验室检查,其中26,709例(46.4%)至少一项结果异常。
- 与接受检查相关的因素包括年龄增加、女性、非白人种族/族裔、ASA 2级、糖尿病、呼吸困难、高血压、肥胖和类固醇使用。
- 预防严重并发症的需检查人数为599,预防任何并发症的需检查人数为133。
临床怎么用
- 对ASA 1-2级低风险门诊手术患者,应遵循指南避免常规术前实验室检查。
- 需权衡检查的边际效益与成本,识别真正需要检查的高危因素(如年龄、糖尿病、高血压等)。
- 更审慎的检查策略可能在不增加并发症风险的前提下显著节约医疗费用。
局限性
- 回顾性研究设计,可能存在选择偏倚和混杂因素。
- 仅纳入2017年NSQIP数据,结果外推需谨慎。
- 检查成本基于CMS数据估算,可能不适用于其他支付体系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Routine preoperative laboratory testing is not recommended for American Society of Anesthesiologists classification 1 or 2 patients before low-risk ambulatory surgery. METHODS: The 2017 National Surgical Quality Improvement Program data set was retrospectively queried for American Society of Anesthesiologists class 1 and 2 patients who underwent low-risk, elective outpatient anorectal, breast, endocrine, gynecologic, hernia, otolaryngology, oral-maxillofacial, orthopedic, plastic/reconstructive, urologic, and vascular operations. Preoperative laboratory testing was defined as any chemistry, hematology, coagulation, or liver function studies obtained ≤30 days preoperatively. Demographics, comorbidities, and outcomes were compared between those with and without testing. The numbers needed to test to prevent serious morbidity or any complication were calculated. Laboratory testing costs were estimated using Centers for Medicare and Medicaid Services data. RESULTS: Of 111,589 patients studied, 57,590 (51.6%) received preoperative laboratory testing; 26,709 (46.4%) had at least 1 abnormal result. Factors associated with receiving preoperative laboratory testing included increasing age, female sex, non-White race/ethnicity, American Society of Anesthesiologists class 2, diabetes, dyspnea, hypertension, obesity, and steroid use. Mortality did not differ between patients with and without testing. The complication rate was 2.5% among tested patients and 1.7% among patients without tests (P < .01). The numbers needed to test was 599 for serious morbidity and 133 for any complication. An estimated $373 million annually is spent on preoperative laboratory testing in this population. CONCLUSION: Despite American Society of Anesthesiologists guidelines, a majority of American Society of Anesthesiologists class 1 and 2 patients undergo preoperative laboratory testing before elective low-risk outpatient surgery. The differences in the rates of complications between patients with and without testing is low. Preoperative testing should be used more judiciously in this population, which may lead to cost savings.
引用
- Taylor GA, Oresanya LB, Kling SM, et al. Rethinking the routine: Preoperative laboratory testing among American Society of Anesthesiologists class 1 and 2 patients before low-risk ambulatory surgery in the 2017 National Surgical Quality Improvement Program cohort. Surgery. 2021. PMID: 34465470. doi:10.1016/j.surg.2021.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。